Categories AlphaGraphs, Earnings, Health Care

Biogen tops market estimates in Q3, lowers guidance

Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in Q3 revenues to $3.38 billion, beating the Wall Street consensus. Earnings of $8.84 per share were also stronger than what analysts had anticipated.

BIIB shares were trading flat immediately following the announcement. The stock has slipped 9% since the beginning of this year.

Biogen Q3 2020 earnings.

Looking forward to listening to management/ analyst comments on Q4 results? Stay tuned here for Biogen Q3 2020 earnings call transcript

Biogen also lowered its guidance for the full year, hurt by multiple Tecfidera generic entrants in the US.

Prior performance

Most Popular

AVGO Earnings: Highlights of Broadcom’s Q4 2022 report

Chipmaker Broadcom, Inc. (NASDAQ: AVGO) Thursday reported better-than-expected earnings and revenues for the fourth quarter of 2022. Net profit was $10.45 per share in the final three months of the

COST Earnings: All you need to know about Costco Wholesale Corporation’s Q1 2023 earnings results

Costco Wholesale Corporation (NASDAQ: COST) reported first quarter 2023 earnings results today. Net sales increased 8.1% to $53.44 billion compared to the same period a year ago. Comparable sales were up

Three factors that bode well for Campbell Soup (CPB) in the current environment

Shares of Campbell Soup Company (NYSE: CPB) were up 1% on Thursday. The stock has gained 30% year-to-date and 34% over the past 12 months. The food company started the

Add Comment
Viewing Highlight